Status:
COMPLETED
Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction
Lead Sponsor:
Arizona State University
Conditions:
Inflammation
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The purpose of this trial is to determine the effect of maqui extract plus omega-3 fatty acids compared to a placebo for reducing inflammatory cytokine levels in older, obese adults.
Detailed Description
Anthocyanins, a subclass of flavonoids, are plant pigments that provide the rich color of many plants, fruits, and flowers. Health benefits of anthocyanins have been widely reported in the research li...
Eligibility Criteria
Inclusion
- Males and females 50-85 years old
- Generally healthy, non-smoker
- Able to provide informed consent
- BMI: 30-40 kg/m2
Exclusion
- Existing auto-immune conditions
- Use of warfarin or other blood thinners
- Use of anti-inflammatory drugs, cardiovascular medications, lipid-altering drugs, and hormone replacement therapy
- Individuals engaged in vigorous exercise (\>2 x 30 min/week), vegetarians, and people who routinely take multivitamins or herbal supplements.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04914312
Start Date
January 15 2022
End Date
August 15 2023
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona State University
Phoenix, Arizona, United States, 85004